We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Quarterly reports on acquired carbapenemase-producing Gram-negative organisms (CPOs) identified in human samples in England.
Evaluation of the Shingrix® herpes zoster (shingles) vaccination programme in England: academic year 2023 to 2024.
Annual counts and rates of Escherichia coli (E. coli) bacteraemia by acute trust and sub-integrated care board location (SICBL).
Annual counts and rates of meticillin susceptible Staphylococcus aureus (MSSA) bacteraemia by acute trust and sub-integrated care board location (SICBL).
Trends in MRSA, MSSA, E. coli, Klebsiella spp. and P. aeruginosa bacteraemia and C. difficile infection by financial year.
Annual counts and rates of C. difficile infections (CDI) by acute trust and sub-integrated care board location (SICBL) in patients aged 2 years and over.
Annual counts and rates of Pseudomonas aeruginosa (P. aeruginosa) bacteraemia by NHS acute trust and sub-integrated care board location (SICBL).
Annual counts and rates of Klebsiella species (Klebsiella spp.) bacteraemia by NHS acute trust and sub-integrated care board location (SICBL).
Technical briefing documents on the investigation into cases of mpox in England.
Measles notifications and deaths in England and Wales.
Latest UKHSA hepatitis B virus report and supporting document for England.
An examination of the epidemiology of syphilis in England presented by demographic characteristics to illustrate how different groups are affected.
A yearly overview of influenza surveillance results from the winter period.
Epidemiological information relating to ceftriaxone-resistant Neisseria gonorrhoeae in England.
Evaluation report on uptake of the measles, mumps and rubella (MMR) vaccine during national and regional MMR catch-up activities in 2023 to 2024 in England.
Laboratory-confirmed cases of invasive meningococcal disease reported to the enhanced meningococcal surveillance programme in England.
Annual data on reported cases of diphtheria in England, with epidemiological commentary.
Laboratory reports on cases of Haemophilus influenzae in England.
Number of laboratory confirmed cases of parvovirus B19 infection in women aged 15 to 44 years in England.
Evaluation of the eleventh year of the Zostavax® shingles vaccination programme in England: financial year 2023 to 2024.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).